Loading clinical trials...
Loading clinical trials...
An Open-Label, Dose-Escalation Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of MRG-001 in Patients With Alcoholic Hepatitis
Conditions
Interventions
MRG-001
Start Date
September 1, 2024
Primary Completion Date
September 1, 2026
Completion Date
December 1, 2026
Last Updated
March 13, 2024
NCT04088370
NCT06159244
NCT06919458
NCT02344680
NCT06285253
NCT03149627
Lead Sponsor
MedRegen LLC
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions